Literature DB >> 8887037

Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis. Lack of correlation with hepatitis C and D virus superinfection.

L C Da Silva1, C L Madruga, F J Carrilho, J R Pinho, A Saéz-Alquezar, C Santos, L Bassit, C Barreto, L E Fonseca, V A Alves, R Leitão, R Vianna, R A Cardoso, A V França, L C Gayotto.   

Abstract

We investigated the frequency of HBsAg clearance and the possible role of viral superinfection in a long-term follow-up of 184 patients with chronic hepatitis B (CHB). Our subjects were 184 patients with chronic hepatitis B and the follow-up was 12-216 months (mean 66.2 +/- 53.7 months). The investigative methods used were: immunoenzymatic assays for HBV, HCV, HDV, and HIV markers; polymerase chain reaction (PCR) for HBV DNA; and liver biopsy and immunoperoxidase. During the follow-up, 20 of the 184 patients cleared serum HBsAg. A comparison of patients with persistent HBsAg(group I) and of those who cleared this marker (group II) showed a significant difference in mortality (P = 0.002) between the two groups and a tendency to a more severe exacerbation (flare) in group II (P = 0.07). Antibodies to hepatitis C and D virus as well as antibodies to HIV were equally distributed in both groups. Thirteen patients (7.9%) from group I, but none from group II, subsequently developed hepatocellular carcinoma. These results suggest that the frequency of spontaneous clearance of HBsAg during chronic HBV infection is low. No determinant factor for the clearance was found, including the presence of liver cirrhosis. Serum HBV DNA was undetectable by PCR after clearance in 16 out of 17 patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8887037     DOI: 10.1007/bf02347619

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  34 in total

1.  Clearance of HBsAg in seven patients with chronic hepatitis B.

Authors:  H Adachi; S Kaneko; E Matsushita; Y Inagaki; M Unoura; K Kobayashi
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

2.  Comparison of serum hepatitis B virus replication markers in patients with chronic hepatitis B: studies on HBeAg/anti-HBe system, viral DNA polymerase and HBV-DNA.

Authors:  J R Pinho; L E da Fonseca; Y Song; Y Miyamoto; F J Carrilho; C F Granato; L C da Silva
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1989 Sep-Oct       Impact factor: 1.846

3.  Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapy.

Authors:  P Marcellin; M Martinot-Peignoux; M A Loriot; E Giostra; N Boyer; V Thiers; J P Benhamou
Journal:  Ann Intern Med       Date:  1990-02-01       Impact factor: 25.391

4.  HBsAg clearance in patients with long-standing chronic active hepatitis B and hepatitis B virus-induced liver cirrhosis.

Authors:  T Poralla; M Manns; T H Hütteroth; G Hess; H H Dormeyer; K H Meyer zum Büschenfelde
Journal:  Digestion       Date:  1986       Impact factor: 3.216

5.  The significance of serologic, histologic, and immunohistologic findings in the prognosis of 88 asymptomatic carriers of hepatitis B surface antigen.

Authors:  H H Dormeyer; W Arnold; H Schönborn; B Braun; O Klinge; U Pfeifer; J Knolle; G Hess; P Kryger; J O Nielsen; K H Meyer zum Büschenfelde
Journal:  J Infect Dis       Date:  1981-07       Impact factor: 5.226

6.  Long-term remission of chronic hepatitis B after alpha-interferon therapy.

Authors:  J Korenman; B Baker; J Waggoner; J E Everhart; A M Di Bisceglie; J H Hoofnagle
Journal:  Ann Intern Med       Date:  1991-04-15       Impact factor: 25.391

7.  Hepatitis B virus DNA in peripheral-blood mononuclear cells in chronic hepatitis B after HBsAg clearance.

Authors:  A Mason; B Yoffe; C Noonan; M Mearns; C Campbell; A Kelley; R P Perrillo
Journal:  Hepatology       Date:  1992-07       Impact factor: 17.425

8.  Hepatitis B virus DNA in mononuclear blood cells. A frequent event in hepatitis B surface antigen-positive and -negative patients with acute and chronic liver disease.

Authors:  C Pasquinelli; F Lauré; L Chatenoud; G Beaurin; C Gazengel; H Bismuth; F Degos; P Tiollais; J F Bach; C Bréchot
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

9.  Natural history of chronic persistent hepatitis B. Relationship between hepatitis B virus replication and the course of the disease.

Authors:  J M Sánchez-Tapias; J H Vilar; J Costa; M Bruguera; A M Ballesta; J Rodés
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

10.  Pilot study of recombinant human alpha-interferon for chronic type B hepatitis.

Authors:  J S Dooley; G L Davis; M Peters; J G Waggoner; Z Goodman; J H Hoofnagle
Journal:  Gastroenterology       Date:  1986-01       Impact factor: 22.682

View more
  9 in total

Review 1.  Diagnosis and management of clinical and subclinical cobalamin deficiency: advances and controversies.

Authors:  Ralph Carmel; Mona Sarrai
Journal:  Curr Hematol Rep       Date:  2006-03

2.  Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses.

Authors:  Kali Zhou; Caitlin Contag; Evans Whitaker; Norah Terrault
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-01-22

3.  Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.

Authors:  Wendy K Foster; Darren S Miller; Catherine A Scougall; Ieva Kotlarski; Richard J Colonno; Allison R Jilbert
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Ethnic differences in incidence of hepatitis B surface antigen seroclearance in a real-life multicenter clinical cohort of 4737 patients with chronic hepatitis B infection.

Authors:  L H Nguyen; J Hoang; N H Nguyen; V D Vu; C Wang; H N Trinh; J Li; J Q Zhang; M H Nguyen
Journal:  Aliment Pharmacol Ther       Date:  2016-07-01       Impact factor: 8.171

5.  HBsAg may reappear following reactivation in individuals with spontaneous HBsAg seroclearance 8 years previously.

Authors:  Q Y Chen; X Y Wang; T J Harrison; X He; L P Hu; K W Li; H H Jia; Q L Yang; C Wang; Z L Fang
Journal:  Epidemiol Infect       Date:  2016-12-05       Impact factor: 4.434

6.  Sequence variations of full-length hepatitis B virus genomes in Chinese patients with HBsAg-negative hepatitis B infection.

Authors:  Fung-Yu Huang; Danny Ka-Ho Wong; Wai-Kay Seto; An-Ye Zhang; Cheuk-Kwong Lee; Che-Kit Lin; James Fung; Ching-Lung Lai; Man-Fung Yuen
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

Review 7.  Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg).

Authors:  Satinder P Kaur; Arslan Talat; Hamidreza Karimi-Sari; Andrew Grees; Hao Wei Chen; Daryl T Y Lau; Andreea M Catana
Journal:  J Clin Med       Date:  2022-02-21       Impact factor: 4.241

8.  Clinical outcomes of delayed clearance of serum HBsAG in patients with chronic HBV infection.

Authors:  Soon Woo Nam; Jeong Jo Jung; Si Hyun Bae; Jong Young Choi; Seung Kew Yoon; Se Hyun Cho; Joon Yeol Han; Nam Ik Han; Jin Mo Yang; Young Suk Lee
Journal:  Korean J Intern Med       Date:  2007-06       Impact factor: 2.884

Review 9.  Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma.

Authors:  Chiao-Fang Teng; Han-Chieh Wu; Ih-Jen Su; Long-Bin Jeng
Journal:  Viruses       Date:  2020-08-26       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.